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Thioctic or alpha-lipoic acid (ALA) is a naturally occurring antioxidant. It has two 
optical isomers designated as (R+) and (S-). Naturally occurring ALA is the (R+)-iso-
form, but synthetic ALA available as a registered drug or as a nutraceutical is a mixture 
of (R+) and (S-)-isoforms. ALA has been proposed as a potential therapeutic agent in the 
treatment or prevention of several pathologies related to an imbalance of the oxidore-
ductive status. Oxidative stress may have a relevant role in the development of neuro-
logical disorders. Peripheral neuropathy is one of these disorders characterized by mye-
lin damage and axonal degeneration causing chronic pain syndromes with allodynia, 
hyperalgesia, altered sensitive information processing and impaired nerve function.
The present study was designed to assess if compression of sciatic nerve, induced 
by loose ligation of it, is accompanied by an increased oxidative stress and by cen-
tral nervous system damage. This study has also investigated the role of ALA enanti-
ometers treatment in preventing damage related to oxidative stress. Loose ligation of 
the right sciatic nerve was performed in spontaneously hypertensive rats (SHR), used 
as a model of enhanced oxidative stress, and normotensive Wistar-Kyoto rats (WKY) 
used as a reference group. Animals with sciatic nerve ligation were left untreated or 
were treated intraperitoneally for 14 days with racemic-ALA (25 and 50 mg/Kg/day), 
(R+)-ALA(25 mg/Kg/day), (S-)-ALA (25 mg/Kg/day) and with the anticonvulsant 
agent used in treating neuropathic pain pregabalin (50 mg/Kg/day).
Loose ligation increased astrogliosis in lumbar spinal cord and in brain at the lev-
els of primary and secondary motor and general sensory cortices. Astrogliosis is prob-
ably related to the increase of oxidative stress in the model of compressive neuropathy 
used. Treatment for 14 days with (R+)-thioctic acid decreased the number and size of 
astrocytes, racemic-ALA was less eff ective, whereas the (S-) enantiomer and pregaba-
lin were without eff ect. Moreover, in the brain of SHR neuronal damage and decreased 
expression of neurofi lament phosphorilated (NFP) protein was noticeable. The number 
of neurons and the expression of NFP were not aff ected by antioxidant treatment.
The present study has documented the occurrence of microanatomical changes in 
the central nervous system consequent to peripheral nerve damage. These changes 
are countered by antioxidant treatment being (R+)-thioctic acid the most eff ective 
agent. This may have consequences in terms of clinical applications.
Keywords: Neuropathy, brain, oxidative stress, antioxidant treatments
